Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Novel tumor suppressor candidates on chromosome 3 revealed by NotI-microarrays in cervical cancer.

Senchenko VN, Kisseljova NP, Ivanova TA, Dmitriev AA, Krasnov GS, Kudryavtseva AV, Panasenko GV, Tsitrin EB, Lerman MI, Kisseljov FL, Kashuba VI, Zabarovsky ER.

Epigenetics. 2013 Apr;8(4):409-20. doi: 10.4161/epi.24233. Epub 2013 Mar 11.

2.

Genetic and epigenetic analysis of non-small cell lung cancer with NotI-microarrays.

Dmitriev AA, Kashuba VI, Haraldson K, Senchenko VN, Pavlova TV, Kudryavtseva AV, Anedchenko EA, Krasnov GS, Pronina IV, Loginov VI, Kondratieva TT, Kazubskaya TP, Braga EA, Yenamandra SP, Ignatjev I, Ernberg I, Klein G, Lerman MI, Zabarovsky ER.

Epigenetics. 2012 May;7(5):502-13. doi: 10.4161/epi.19801. Epub 2012 May 1.

PMID:
22491060
3.

[Down-regulation of RBSP3/CTDSPL, NPRL2/G21, RASSF1A, ITGA9, HYAL1 and HYAL2 genes in non-small cell lung cancer].

Anedchenko EA, Dmitriev AA, Krasnov GS, Kondrat'eva TT, Kopantsev EP, Vinogradova TV, Zinov'eva MV, Zborovskaia IB, Polotskiĭ BE, Sakharova OV, Kashuba VI, Zabarovskiĭ ER, Senchenko VN.

Mol Biol (Mosk). 2008 Nov-Dec;42(6):965-76. Russian.

PMID:
19140316
4.

Simultaneous down-regulation of tumor suppressor genes RBSP3/CTDSPL, NPRL2/G21 and RASSF1A in primary non-small cell lung cancer.

Senchenko VN, Anedchenko EA, Kondratieva TT, Krasnov GS, Dmitriev AA, Zabarovska VI, Pavlova TV, Kashuba VI, Lerman MI, Zabarovsky ER.

BMC Cancer. 2010 Mar 1;10:75. doi: 10.1186/1471-2407-10-75.

5.

Epigenetic alterations of chromosome 3 revealed by NotI-microarrays in clear cell renal cell carcinoma.

Dmitriev AA, Rudenko EE, Kudryavtseva AV, Krasnov GS, Gordiyuk VV, Melnikova NV, Stakhovsky EO, Kononenko OA, Pavlova LS, Kondratieva TT, Alekseev BY, Braga EA, Senchenko VN, Kashuba VI.

Biomed Res Int. 2014;2014:735292. doi: 10.1155/2014/735292. Epub 2014 May 22.

6.

Hypermethylation of the tumor suppressor gene RASSFIA and frequent concomitant loss of heterozygosity at 3p21 in cervical cancers.

Yu MY, Tong JH, Chan PK, Lee TL, Chan MW, Chan AW, Lo KW, To KF.

Int J Cancer. 2003 Jun 10;105(2):204-9.

7.

The RASSF1A tumor suppressor gene is commonly inactivated in adenocarcinoma of the uterine cervix.

Cohen Y, Singer G, Lavie O, Dong SM, Beller U, Sidransky D.

Clin Cancer Res. 2003 Aug 1;9(8):2981-4.

8.

[Technology of analysis of epigenetic and structural changes of epithelial tumors genome with NotI-microarrays by the example of human chromosome].

Pavlova TV, Kashuba VI, Muravenko OV, Yenamandra SP, Ivanova TA, Zabarovskaia VI, Rakhmanaliev ER, Petrenko LA, Pronina IV, Loginov VI, Iurkevich OIu, Kiselev LL, Zelenin AV, Zabarovskiĭ ER.

Mol Biol (Mosk). 2009 Mar-Apr;43(2):339-47. Russian.

PMID:
19425501
9.
10.

Hypermethylation of two consecutive tumor suppressor genes, BLU and RASSF1A, located at 3p21.3 in cervical neoplasias.

Lai HC, Lin YW, Chang CC, Wang HC, Chu TW, Yu MH, Chu TY.

Gynecol Oncol. 2007 Mar;104(3):629-35. Epub 2006 Nov 13.

PMID:
17097722
11.

[Methylation of the putative tumor suppressor gene, RASSF1A, in primary cervical tumors].

Maliukova AV, Loginov VI, Khodyrev DS, Kadyrova EL, Pronina IV, Ivanova TA, Kiselev FL, Zabarovskiĭ NP, Braga EA.

Mol Biol (Mosk). 2004 Nov-Dec;38(6):1005-13. Russian.

PMID:
15612586
12.

NotI microarrays: novel epigenetic markers for early detection and prognosis of high grade serous ovarian cancer.

Kashuba V, Dmitriev AA, Krasnov GS, Pavlova T, Ignatjev I, Gordiyuk VV, Gerashchenko AV, Braga EA, Yenamandra SP, Lerman M, Senchenko VN, Zabarovsky E.

Int J Mol Sci. 2012 Oct 18;13(10):13352-77. doi: 10.3390/ijms131013352.

13.

[Identification of changes in gene loci potentially associated with cervical cancer using NotI microarrays].

Kashuba VI, Skripkina IIa, Saraev DV, Gordiiuk VV, Vinnitskaia AB, Tsyba LA, Pogrebnoĭ PV, Blinov VM, Zabarovskiĭ ER, Ryndich AV.

Ukr Biokhim Zh (1999). 2006 Mar-Apr;78(2):113-20. Russian.

PMID:
17100293
14.

Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours.

Agathanggelou A, Honorio S, Macartney DP, Martinez A, Dallol A, Rader J, Fullwood P, Chauhan A, Walker R, Shaw JA, Hosoe S, Lerman MI, Minna JD, Maher ER, Latif F.

Oncogene. 2001 Mar 22;20(12):1509-18.

15.

Frequent 3p allele loss and epigenetic inactivation of the RASSF1A tumour suppressor gene from region 3p21.3 in head and neck squamous cell carcinoma.

Hogg RP, Honorio S, Martinez A, Agathanggelou A, Dallol A, Fullwood P, Weichselbaum R, Kuo MJ, Maher ER, Latif F.

Eur J Cancer. 2002 Aug;38(12):1585-92.

PMID:
12142046
16.

An integrated physical and gene map of the 3.5-Mb chromosome 3p21.3 (AP20) region implicated in major human epithelial malignancies.

Protopopov A, Kashuba V, Zabarovska VI, Muravenko OV, Lerman MI, Klein G, Zabarovsky ER.

Cancer Res. 2003 Jan 15;63(2):404-12.

17.

RBSP3 is frequently altered in premalignant cervical lesions: clinical and prognostic significance.

Mitra S, Mazumder Indra D, Bhattacharya N, Singh RK, Basu PS, Mondal RK, Roy A, Zabarovsky ER, Roychoudhury S, Panda CK.

Genes Chromosomes Cancer. 2010 Feb;49(2):155-70. doi: 10.1002/gcc.20726.

PMID:
19885927
18.

Distinct DNA methylation profiles between adenocarcinoma and squamous cell carcinoma of human uterine cervix.

Lee EJ, Mcclelland M, Wang Y, Long F, Choi SH, Lee JH.

Oncol Res. 2010;18(9):401-8.

PMID:
20524398
19.

Frequent epigenetic inactivation of RASSF1A in human bladder carcinoma.

Lee MG, Kim HY, Byun DS, Lee SJ, Lee CH, Kim JI, Chang SG, Chi SG.

Cancer Res. 2001 Sep 15;61(18):6688-92.

20.

Chromosome 3p tumor-suppressor gene alterations in cervical carcinomas.

Herzog CR, Crist KA, Sabourin CL, Kelloff GJ, Boone CW, Stoner GD, You M.

Mol Carcinog. 2001 Mar;30(3):159-68.

PMID:
11301476

Supplemental Content

Support Center